IP Library › Granted Patent US 11,771,838
Granted Patent B2
US 11,771,838 · App. 16/328,251 · Granted Oct 3, 2023

Audible indicator

Inventors: Michael Helmer (Frankfurt am Main, DE); Marc Schader (Frankfurt am Main, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/3157A61M5/2033A61M2205/581
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,838
App. No.
16/328,251
Granted
Oct 3, 2023
Kind
B2
Abstract

The present disclosure relates to an audible indicator for use with a drug delivery device comprising a resilient force member configured to reside in one of a relaxed state and a biased state. The audible indicator comprises a retainer adapted to maintain the resilient force member in the biased state. The resilient force member releases stored energy to impact a surface to generate an audible signal when the resilient force member changes from the biased state into the relaxed state.

Claims (31)

1. An audible indicator for use with a drug delivery device, the audible indicator comprising:

a resilient force member configured to reside in one of a relaxed state and a biased state, and

a retainer comprising a movable support arm adapted to radially inwardly abut a plunger to maintain the resilient force member in the biased state when the plunger is in a proximal position,

wherein the resilient force member is configured to release stored energy to impact a surface to generate an audible signal when the resilient force member changes from the biased state into the relaxed state; wherein the resilient force member is configured to disengage from the movable support arm, and wherein the resilient force member is in the relaxed state after disengaging from the movable support arm.

2. The audible indicator according to claim 1 , wherein the resilient force member comprises a resilient material.

3. The audible indicator according to claim 1 , wherein the resilient force member comprises a center portion and two legs such that the resilient force member assumes an Ω-shaped, U-shaped or horseshoe-shaped cross section in the biased state.

4. The audible indicator according to claim 1 , wherein the retainer comprises a notch formed in the support arm, the notch being configured to receive legs of the resilient force member when the resilient force member is in the biased state.

5. The audible indicator according to claim 1 , wherein the retainer comprises a radially outwardly directed beam having a protrusion on the support arm, wherein a second end of the resilient force member is retained by the protrusion when the resilient force member is in the biased state.

6. The audible indicator according to claim 1 , wherein the resilient force member is a leaf spring having a first end configured to be fixed and a free second end.

7. The indicator device of claim 1 , wherein the plunger is translatable in a distal direction relative to the retainer.

8. A drug delivery device, comprising:

a case,

a plunger, and

an audible indicator comprising

a resilient force member configured to reside in one of a relaxed state and a biased state, and

a retainer comprising a movable support arm adapted to radially inwardly abut the plunger to maintain the resilient force member in the biased state when the plunger is in a proximal position,

wherein the resilient force member is configured to release stored energy to impact a surface of the case to generate an audible signal when the resilient force member changes from the biased state into the relaxed state; wherein the resilient force member is configured to disengage from the movable support arm, and wherein the resilient force member is in the relaxed state after disengaging from the movable support arm.

9. The drug delivery device according to claim 8 , wherein the resilient force member is configured to change from the biased state into the relaxed state by a movement of the plunger.

10. The drug delivery device according to claim 9 , wherein the resilient force member is configured to change from the biased state into the relaxed state by the movement of the plunger towards a distal position at an end of a medicament delivery process.

11. The drug delivery device according to claim 9 , wherein a center or first end of the resilient force member is coupled to the case.

12. The drug delivery device according to claim 8 , wherein the support arm is resiliently coupled to the case.

13. The drug delivery device according to claim 8 , wherein the support arm extends substantially in parallel with a longitudinal axis of the drug delivery device.

14. The drug delivery device according to claim 8 , wherein, when a proximal end of the plunger passes the support arm in a distal direction, the support arm is free to relax radially inwards, pulling legs of the resilient force member out of a notch allowing the legs to relax and strike a surface of the case for generating the audible signal.

15. The drug delivery device according to claim 8 , wherein, when a proximal end of the plunger passes the support arm in a distal direction, the support arm is free to relax radially inwards, displacing a protrusion in the distal direction and releasing a second end of the resilient force member, allowing the resilient force member to relax and strike a surface the case for generating the audible signal.

16. The drug delivery device of claim 8 , wherein the plunger is configured to move in a distal direction relative to the support arm.

17. A method comprising:

containing legs of an audible indicator in a notch of a support arm extending from a plunger of an autoinjector, wherein the support arm comprises a retainer and is configured to radially inwardly abut the plunger when the plunger is in a proximal position, the support arm arranged such that the support arm and the notch extend along a stem of the plunger, wherein the audible indicator is in a biased position,

moving the plunger from a proximal position to a distal position, and

emitting an audible signal by disengaging the legs of the audible indicator from the support arm such that the legs of the audible indicator flex into an unbiased position and contact a case of the autoinjector.

18. The method of claim 17 , wherein moving the plunger from a proximal position to a distal position comprises dispensing medicament from a container of the autoinjector.

19. The method of claim 17 , wherein the audible signal indicates that a dose of a medicament has been dispensed.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2021
From: HELMER, MICHAEL; SCHADER, MARC
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 055419/0101 →
Priority Claims (1)
EP 16185803 · Aug 26, 2016 · regional
Continuity (1)
Related Publication 20210275750A1 · Sep 9, 2021